This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gillum, R. F. Search for Related Content PubMed PubMed Citation Articles by Gillum, R. F. Pubmed/NCBI databases OMIM Medline Plus Health Information High Blood Pressure

Hypertension, Vol 1, 468-475, Copyright © 1979 by American Heart Association

ARTICLES

Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences

RF Gillum

Differences in blood pressure between blacks and whites in the United States are now well documented. The causes of these differences remain speculative. Genetic factors, personal characteristics, renal physiology, endocrine factors, autonomic nervous system function, cardiac function and various environmental factors are examined in the present review as potential determinants of racial blood pressure differences. Racial differences in renal physiology and environmental influences such as socioeconomic status seem to be likely candidates for important contributions to blood pressure differences. Further research aimed specifically at black-white blood pressure differences is of great importance to a fundamental understanding of the etiology and prevention of essential hypertension.

This article has been cited by other articles:

				A. A. Quyyumi Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S66 - S71. [Abstract] [Full Text] [PDF]

				A. L. Taylor, J. T. Wright Jr, R. S. Cooper, B. M. Psaty, A. L. Taylor, J. T. Wright Jr, R. S. Cooper, and B. M. Psaty Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Circulation, December 6, 2005; 112(23): 3654 - 3666. [Full Text] [PDF]

				A. L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel, et al. Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure N. Engl. J. Med., November 11, 2004; 351(20): 2049 - 2057. [Abstract] [Full Text] [PDF]

				T. Y. Wong, R. Klein, B. B. Duncan, F. J. Nieto, B. E.K. Klein, D. J. Couper, L. D. Hubbard, and A. R. Sharrett Racial Differences in the Prevalence of Hypertensive Retinopathy Hypertension, May 1, 2003; 41(5): 1086 - 1091. [Abstract] [Full Text] [PDF]

				U. Campia, W. K. Choucair, M. B. Bryant, M. A. Waclawiw, C. Cardillo, and J. A. Panza Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans J. Am. Coll. Cardiol., August 21, 2002; 40(4): 754 - 760. [Abstract] [Full Text] [PDF]

				D. F. Kahn, S. J. Duffy, D. Tomasian, M. Holbrook, L. Rescorl, J. Russell, N. Gokce, J. Loscalzo, and J. A. Vita Effects of Black Race on Forearm Resistance Vessel Function Hypertension, August 1, 2002; 40(2): 195 - 201. [Abstract] [Full Text] [PDF]

				C. Cardillo, C. M. Kilcoyne, R. O. Cannon III, and J. A. Panza Attenuation of Cyclic Nucleotide–Mediated Smooth Muscle Relaxation in Blacks as a Cause of Racial Differences in Vasodilator Function Circulation, January 12, 1999; 99(1): 90 - 95. [Abstract] [Full Text] [PDF]

				C. Cardillo, C. M. Kilcoyne, R. O. Cannon III, and J. A. Panza Racial Differences in Nitric Oxide–Mediated Vasodilator Response to Mental Stress in the Forearm Circulation Hypertension, June 1, 1998; 31(6): 1235 - 1239. [Abstract] [Full Text] [PDF]

				M. R. Weir, S. G. Chrysant, D. A. McCarron, M. Canossa-Terris, J. D. Cohen, P. A. Gunter, A. J. Lewin, R. F. Mennella, L. W. Kirkegaard, J. H. Hamilton, et al. Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives Hypertension, May 1, 1998; 31(5): 1088 - 1096. [Abstract] [Full Text] [PDF]

				S. R. Daniels, R. P. McMahon, E. Obarzanek, M. A. Waclawiw, S. L. Similo, F. M. Biro, G. B. Schreiber, S. Y. S. Kimm, J. A. Morrison, and B. A. Barton Longitudinal Correlates of Change in Blood Pressure in Adolescent Girls Hypertension, January 1, 1998; 31(1): 97 - 103. [Abstract] [Full Text] [PDF]

				C. C. Lang, C. M. Stein, H. B. He, F. J. Belas, I. A. Blair, M. Wood, and A. J. J. Wood Blunted Blood Pressure Response to Central Sympathoinhibition in Normotensive Blacks : Increased Importance of Nonsympathetic Factors in Blood Pressure Maintenance in Blacks Hypertension, August 1, 1997; 30(2): 157 - 162. [Abstract] [Full Text]

				S. Ergul, D. C. Parish, D. Puett, and A. Ergul Racial Differences in Plasma Endothelin-1 Concentrations in Individuals With Essential Hypertension Hypertension, October 1, 1996; 28(4): 652 - 655. [Abstract] [Full Text]

				D. K. Arnett, H. A. Tyroler, G. Burke, R. Hutchinson, G. Howard, and G. Heiss Hypertension and Subclinical Carotid Artery Atherosclerosis in Blacks and Whites: The Atherosclerosis Risk in Communities Study Arch Intern Med, September 23, 1996; 156(17): 1983 - 1989. [Abstract] [PDF]

				C. C. Lang, C. M. Stein, R. M. Brown, R. Deegan, R. Nelson, H. B. He, M. Wood, and A. J.J. Wood Attenuation of Isoproterenol-Mediated Vasodilatation in Blacks N. Engl. J. Med., July 20, 1995; 333(3): 155 - 160. [Abstract] [Full Text] [PDF]

				M. R. Weir, J. M. Gray, R. Paster, and E. Saunders Differing Mechanisms of Action of Angiotensin-Converting Enzyme Inhibition in Black and White Hypertensive Patients Hypertension, July 1, 1995; 26(1): 124 - 130. [Abstract] [Full Text]

				B. Falkner, H. Kushner, S. Levison, and M. Canessa Albuminuria in Association With Insulin and Sodium-Lithium Countertransport in Young African Americans With Borderline Hypertension Hypertension, June 1, 1995; 25(6): 1315 - 1321. [Abstract] [Full Text]

				M. Phillips The Use of Race in Medical Research JAMA, June 17, 1992; 267(23): 3150 - 3151. [Abstract] [PDF]

				M. J. Klag, P. K. Whelton, J. Coresh, C. E. Grim, and L. H. Kuller The Association of Skin Color With Blood Pressure in US Blacks With Low Socioeconomic Status JAMA, February 6, 1991; 265(5): 599 - 602. [Abstract] [PDF]

				E. Saunders, M. R. Weir, B. W. Kong, J. Hollifield, J. Gray, V. Vertes, J. R. Sowers, M. B. Zemel, C. Curry, J. Schoenberger, et al. A Comparison of the Efficacy and Safety of a {beta}-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive Blacks Arch Intern Med, August 1, 1990; 150(8): 1707 - 1713. [Abstract] [PDF]

				S. Sesoko, N. Akema, T. Matsukawa, and Y. Kaneko Predisposing Factors for the Development of Malignant Essential Hypertension Arch Intern Med, October 1, 1987; 147(10): 1721 - 1724. [Abstract] [PDF]

				Veterans Administration Cooperative Study Group on Comparison of Propranolol and Hydrochlorothiazide for the Initial Treatment of Hypertension: I. Results of Short-term Titration With Emphasis on Racial Differences in Response JAMA, October 22, 1982; 248(16): 1996 - 2003. [Abstract] [PDF]